Skip to main content

Table 4 Adverse events experienced by patients in the study (n = 66)

From: Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma

Toxicity grade of adverse event

Number of patients (percent) N = 66

0

35 (53%)

1

19 (29%)

2

7 (11%)

3

2 (3%)

4

3 (5%)

Case descriptions of grade 3 and 4 toxicity description (case by case)

Case 1, grade 3

Grade 2 stomatitis, grade 3 diarrhea

Case 2, grade 3

Grade 3 diarrhea, stool incontinence

Case 3, grade 4

Grade 4 diarrhea

Case 4, grade 4

Grade 4 diarrhea, stool incontinence

Case 5, grade 4

Grade 4 diarrhea

  1. The adverse events experienced by patients in the study, including nausea, vomiting, stomatitis or diarrhea are shown in the top of the table. The lower half includes a more detailed description of each of the five grade 3 and 4 adverse events.